Cara Therapeutics Files 2024 10-K
Ticker: TVRD · Form: 10-K · Filed: Mar 11, 2025 · CIK: 1346830
| Field | Detail |
|---|---|
| Company | Cara Therapeutics, Inc. (TVRD) |
| Form Type | 10-K |
| Filed Date | Mar 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
Cara Therapeutics filed its 2024 10-K on March 11, 2025, detailing its financial performance and business operations.
AI Summary
Cara Therapeutics, Inc. filed its 2024 10-K on March 11, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The filing details the company's business operations, financial condition, and risk factors. Key financial data and operational highlights for the period are presented within the report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Cara Therapeutics' financial health and strategic direction for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Cara Therapeutics faces inherent risks related to drug development, regulatory approvals, market competition, and intellectual property.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-11 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Cara Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-11 (date) — Filing date
- 0001346830 (company) — Central Index Key
- 203-406-3700 (dollar_amount) — Business phone number
FAQ
What is Cara Therapeutics' primary business focus as indicated in the filing?
The filing identifies Cara Therapeutics, Inc. under the Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations, indicating its primary business is in this sector.
When did Cara Therapeutics, Inc. change its former name?
The company formerly known as Cara Therapeutics Inc. changed its name on December 13, 2005.
What is the SEC file number for Cara Therapeutics, Inc.'s 10-K filing?
The SEC file number for this filing is 001-36279.
What is the state of incorporation for Cara Therapeutics, Inc.?
Cara Therapeutics, Inc. is incorporated in Delaware (DE).
What is the business address of Cara Therapeutics, Inc.?
The business address is 400 Atlantic Street, Suite 500, Stamford, CT 06901.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 11, 2025 regarding Cara Therapeutics, Inc. (TVRD).